LIMD1 and invasive breast carcinoma: Results from these different portals show that LIMD1 transcript is significantly downregulated in NSCLC (LUAD and LUSC), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS), and upregulated in lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), breast cancer (BRCA), glioblastoma multiforme (GBM), acute myeloid leukemia (LAML), and brain lower-grade glioma (LGG) (Figures 2A-C; Figure 5C; Supplementary.